Gene Therapy of Salivary Diseases
For many years, our research group worked to develop gene transfer approaches for salivary gland disorders that lacked effective conventional therapy. The purpose of this chapter is to describe and update key methods used in this process. As described in our original chapter from the 2010 volume, we focus on one clinical condition, irradiation-induced salivary hypofunction, and address the choice of transgene and vector to be used, the construction of recombinant viral vectors, how vector delivery is accomplished, and methods for assessing vector function in vitro and in an appropriate animal model.
Key wordsGene therapy Salivary glands Adenovirus Adeno-associated virus Radiation damage Salivary hypofunction
The authors’ research is supported by the intramural research program of the National Institute of Dental and Craniofacial Research.
- 3.Kok MR, Yamano S, Lodde BM, Wang J, Couwenhoven RI, Yakar S, Voutetakis A, Leroith D, Schmidt M, Afione S, Pillemer SR, Tsutsui MT, Tak PP, Chiorini JA, Baum BJ (2003) Local adeno-associated virus-mediated interleukin 10 gene transfer has disease-modifying effects in a murine model of Sjögren’s syndrome. Hum Gene Ther 14:1605–1618CrossRefPubMedGoogle Scholar
- 19.Cotrim AP, Hyodo F, Matsumoto K, Sowers AL, Cook JA, Baum BJ, Krishna MC, Mitchell JB (2007) Differential radiation protection of salivary glands versus tumor by Tempol with accompanying tissue assessment of Tempol by magnetic resonance imaging. Clin Cancer Res 13:4928–4933CrossRefPubMedGoogle Scholar
- 21.Smith RH, Afione S, Kotin RM (2002) Transposase-mediated construction of an integrated adeno associated virus type 5 helper plasmid. Biotechniques 208:210–211Google Scholar